However, analysis of 30 pseudopolyp samples resected from 30 IBD patients identified mutations in CDKN2A, tP53-exon7, and K-RAS genes in nearly 15% of the lesions [29]. This evidence concerns the gene KRAS and inflammatory bowel disease.